NCT03543228View on ClinicalTrials.gov

MyoStrain CMR for the Detection of Cardiotoxicity

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
CardiotoxicityHeart FailureChemotherapeutic Toxicity
Interventions
DIAGNOSTIC_TEST

MyoStrain

MyoStrain quantifies myocardial contraction to detect changes in heart function during chemotherapy.

Trial Locations (1)

22087

Marien Krankenhaus GmbH, Hamburg

Sponsors
All Listed Sponsors
lead

Myocardial Solutions

INDUSTRY

NCT03543228 - MyoStrain CMR for the Detection of Cardiotoxicity | Biotech Hunter | Biotech Hunter